Global Opioids Drug Market Insights, Research, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 118

Report ID: 17189

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Opioids Drug market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Opioids Drug market based on company, product type, end user and key regions.

This report studies the global market size of Opioids Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Opioids Drug in these regions.
This research report categorizes the global Opioids Drug market by top players/brands, region, type and end user. This report also studies the global Opioids Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm

Market size by Product
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market size by End User
Pain Relief
Anesthesia
Other

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Opioids Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Opioids Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Opioids Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Opioids Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Opioids Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Opioids Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Opioids Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Opioids Drug Market Size Growth Rate by Product
1.4.2 Oxycodone
1.4.3 Hydromorphone
1.4.4 Codeine
1.4.5 Fentanyl
1.4.6 Other
1.5 Market by End User
1.5.1 Global Opioids Drug Market Size Growth Rate by End User
1.5.2 Pain Relief
1.5.3 Anesthesia
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Opioids Drug Market Size
2.1.1 Global Opioids Drug Revenue 2014-2025
2.1.2 Global Opioids Drug Sales 2014-2025
2.2 Opioids Drug Growth Rate by Regions
2.2.1 Global Opioids Drug Sales by Regions
2.2.2 Global Opioids Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Opioids Drug Sales by Manufacturers
3.1.1 Opioids Drug Sales by Manufacturers
3.1.2 Opioids Drug Sales Market Share by Manufacturers
3.1.3 Global Opioids Drug Market Concentration Ratio (CR5 and HHI)
3.2 Opioids Drug Revenue by Manufacturers
3.2.1 Opioids Drug Revenue by Manufacturers (2014-2019)
3.2.2 Opioids Drug Revenue Share by Manufacturers (2014-2019)
3.3 Opioids Drug Price by Manufacturers
3.4 Opioids Drug Manufacturing Base Distribution, Product Types
3.4.1 Opioids Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Opioids Drug Product Type
3.4.3 Date of International Manufacturers Enter into Opioids Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Opioids Drug Sales by Product
4.2 Global Opioids Drug Revenue by Product
4.3 Opioids Drug Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Opioids Drug Breakdown Data by End User

6 North America
6.1 North America Opioids Drug by Countries
6.1.1 North America Opioids Drug Sales by Countries
6.1.2 North America Opioids Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Opioids Drug by Product
6.3 North America Opioids Drug by End User

7 Europe
7.1 Europe Opioids Drug by Countries
7.1.1 Europe Opioids Drug Sales by Countries
7.1.2 Europe Opioids Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Opioids Drug by Product
7.3 Europe Opioids Drug by End User

8 Asia Pacific
8.1 Asia Pacific Opioids Drug by Countries
8.1.1 Asia Pacific Opioids Drug Sales by Countries
8.1.2 Asia Pacific Opioids Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Opioids Drug by Product
8.3 Asia Pacific Opioids Drug by End User

9 Central & South America
9.1 Central & South America Opioids Drug by Countries
9.1.1 Central & South America Opioids Drug Sales by Countries
9.1.2 Central & South America Opioids Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Opioids Drug by Product
9.3 Central & South America Opioids Drug by End User

10 Middle East and Africa
10.1 Middle East and Africa Opioids Drug by Countries
10.1.1 Middle East and Africa Opioids Drug Sales by Countries
10.1.2 Middle East and Africa Opioids Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Opioids Drug by Product
10.3 Middle East and Africa Opioids Drug by End User

11 Company Profiles
11.1 Purdue Pharma
11.1.1 Purdue Pharma Company Details
11.1.2 Company Business Overview
11.1.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Purdue Pharma Opioids Drug Products Offered
11.1.5 Purdue Pharma Recent Development
11.2 J&J
11.2.1 J&J Company Details
11.2.2 Company Business Overview
11.2.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.2.4 J&J Opioids Drug Products Offered
11.2.5 J&J Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Company Business Overview
11.3.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Opioids Drug Products Offered
11.3.5 Teva Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Company Business Overview
11.4.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Mylan Opioids Drug Products Offered
11.4.5 Mylan Recent Development
11.5 Depomed
11.5.1 Depomed Company Details
11.5.2 Company Business Overview
11.5.3 Depomed Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Depomed Opioids Drug Products Offered
11.5.5 Depomed Recent Development
11.6 INSYS
11.6.1 INSYS Company Details
11.6.2 Company Business Overview
11.6.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.6.4 INSYS Opioids Drug Products Offered
11.6.5 INSYS Recent Development
11.7 Endo
11.7.1 Endo Company Details
11.7.2 Company Business Overview
11.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Endo Opioids Drug Products Offered
11.7.5 Endo Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer Opioids Drug Products Offered
11.8.5 Pfizer Recent Development
11.9 Hikma
11.9.1 Hikma Company Details
11.9.2 Company Business Overview
11.9.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Hikma Opioids Drug Products Offered
11.9.5 Hikma Recent Development
11.10 Mallinckrodt
11.10.1 Mallinckrodt Company Details
11.10.2 Company Business Overview
11.10.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Mallinckrodt Opioids Drug Products Offered
11.10.5 Mallinckrodt Recent Development
11.11 Pernix
11.12 Egalet
11.13 Vistapharm

12 Future Forecast
12.1 Opioids Drug Market Forecast by Regions
12.1.1 Global Opioids Drug Sales Forecast by Regions 2019-2025
12.1.2 Global Opioids Drug Revenue Forecast by Regions 2019-2025
12.2 Opioids Drug Market Forecast by Product
12.2.1 Global Opioids Drug Sales Forecast by Product 2019-2025
12.2.2 Global Opioids Drug Revenue Forecast by Product 2019-2025
12.3 Opioids Drug Market Forecast by End User
12.4 North America Opioids Drug Forecast
12.5 Europe Opioids Drug Forecast
12.6 Asia Pacific Opioids Drug Forecast
12.7 Central & South America Opioids Drug Forecast
12.8 Middle East and Africa Opioids Drug Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Opioids Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer